tirzepatide 2.125 mg 💊 — Mechanism of Action & Pharmacokinetics 👨‍⚕️ Mechanism of Action • Tirzepatide is the first dual GIP/GLP-1 receptor agonist. • Activates both: - Glucose-Dependent Insulinotropic Polypeptide (GIP) receptors ✨ Tirzepatide is a once‑weekly

When injected subcutaneously, the medication bypasses digestion and enters the bloodstream directlyproducing more predictable plasma levels, more consistent dosing, and outcomes that are easier to monitor

Most body aches on tirzepatide are mild and manageable

[1] Regular follow-up appointments enable monitoring of both therapeutic response and side effects, with adjustments made as necessary to optimise your treatment whilst maintaining tolerability

The Compounded Channel Is Priced Differently Because It Is Different Compounded semaglutide is a cash-pay category

While it presents a gentler path for many patients, the risks, particularly related to the lack of clinical evidence, are substantial